Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods. - Wikidata - wikimedia - TriplyDB

Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods.

Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods.

http://www.wikidata.org/entity/Q33638578

about

Outcome domains in child mental health research since 1996: have they changed and why does it matter?Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis Anxiety in adolescents: Update on its diagnosis and treatment for primary care providers Online Pestkoppenstoppen: systematic and theory-based development of a web-based tailored intervention for adolescent cyberbully victims to combat and prevent cyberbullying Cognitive behavioral therapy age effects in child and adolescent anxiety: an individual patient data metaanalysis Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS trial.The child anxiety impact scale: examining parent- and child-reported impairment in child anxiety disorders.Benefits of child-focused anxiety treatments for parents and family functioning.The role of neuropsychological assessment in the functional outcomes of children with ADHD.Generalized anxiety disorder and the proposed associated symptoms criterion change for DSM-5 in a treatment-seeking sample of anxious youth Therapist Factors and Outcomes in CBT for Anxiety in Youth Specifying child anxiety disorders not otherwise specified in the DSM-IV.Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome: prevalence and characterization.Aberrant amygdala functional connectivity at rest in pediatric anxiety disorders.Are clinicians' assessments of improvements in children's functioning "global"?Parental psychopathology and treatment outcome for anxious youth: roles of family functioning and caregiver strain Translating Anxiety-Focused CBT for Youth in a First Nations Context in Northwestern Ontario.Child/Adolescent anxiety multimodal study: evaluating safety.Anxiety Disorders in Caucasian and African American Children: A Comparison of Clinical Characteristics, Treatment Process Variables, and Treatment Outcomes Fear of the unknown: uncertain anticipation reveals amygdala alterations in childhood anxiety disorders.The therapeutic relationship in cognitive-behavioral therapy and pharmacotherapy for anxious youth.Predicting Anxiety Diagnoses and Severity with the CBCL-A: Improvement Relative to Other CBCL Scales?Trajectories of change in youth anxiety during cognitive-behavior therapy.Anxiety disorders in fragile X premutation carriers: Preliminary characterization of probands and non-probands.Review: Comprehensive treatments for youth comorbidity - evidence-guided approaches to a complicated problem IQ as a moderator of outcome in severity of children's mental health status after treatment in outpatient clinics.Mediators of change in the Child/Adolescent Anxiety Multimodal Treatment Study.Parenting and depressive symptoms among adolescents in four Caribbean societies Training-associated changes and stability of attention bias in youth: Implications for Attention Bias Modification Treatment for pediatric anxiety.Defining treatment response and remission in child anxiety: signal detection analysis using the pediatric anxiety rating scale.Sleep-Related Problems and the Effects of Anxiety Treatment in Children and Adolescents.Prefrontal Reactivity to Social Signals of Threat as a Predictor of Treatment Response in Anxious Youth.A hybrid effectiveness-implementation cluster randomized trial of group CBT for anxiety in urban schools: rationale, design, and methods Treatment of comorbid anxiety and autism spectrum disorders Pharmacologic Treatment of Pediatric Anxiety Disorders.Assessing anxiety in youth with the multidimensional anxiety scale for children.A probabilistic and individualized approach for predicting treatment gains: an extension and application to anxiety disordered youth.Naturalistic follow-up of youths treated for pediatric anxiety disorders.24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS).Somatic complaints in anxious youth.

P2860

Q26822028-E354C273-6A11-40F9-9808-2CA8A49D66AE Q26824097-FF6650DC-C41A-4D02-B967-975DBB7A26D7 Q27024790-E504EE60-3FD9-4411-A8B8-F22384423698 Q30579458-2891982E-21E8-40B3-BC2E-7FF36357C4A7 Q30622959-4F98049E-09E3-4341-8CC3-082AE42D9916 Q33751389-3F844DAD-198A-440F-A46F-ED6019A2BDD6 Q34065565-E8F49453-C013-4D95-9520-537EF51CB6B8 Q34089588-6310FD10-5A2D-4434-A88A-52CC7D560008 Q34232359-A4890EEA-9749-41A5-8126-A1A4B730BEF9 Q34475300-C7D9C08E-990E-4D4B-A7FB-11EC6F516E8A Q34556915-5245C71C-83BF-4193-9B41-D767749DED2E Q34647185-26B4A626-2177-4D6D-B71E-E61747F9639B Q34669757-3EC78823-DD7C-483C-8807-CA5825DF4119 Q34748698-81E54FFA-9C86-492C-B84F-7DD599708C17 Q34926160-EFA6491D-2262-48B1-A299-790376BFF19A Q35071600-1B2DF9EA-E620-4DF0-B9A1-9923240E90C9 Q35170537-C4BEA8DA-FD24-4EC3-B933-408466B0AB8B Q35185333-A03E6838-EE3E-44F5-807D-2F21021F6DDC Q35327573-3BF359BD-F858-484E-A867-C3EFBEAAB264 Q35421127-5A3BBAF3-D05F-45DE-A8A7-A3CB8FF2A0F1 Q35879243-68BE0894-4A79-4120-8653-0258D57BF9A5 Q35924388-9BA465D9-EE39-47DD-B729-165E4EC18CF7 Q35972712-83F01437-C79C-4D3C-9370-6637655027D6 Q36031757-94FEA98D-60C4-42D4-8A1F-D998248E3252 Q36071771-0FC0A5EC-C794-49E1-8756-2D8BFE56E9FD Q36297232-A5F3F006-815D-423B-AC03-080745663E92 Q36415075-24BA4B14-DF34-4E77-A04B-18FB0CE244F6 Q36462738-29005F5B-8351-49FD-89B6-E791EBE11EB5 Q36709702-13F24EEF-ADCE-4D94-8C30-0FBBB1F539E4 Q36739814-72202206-F740-433D-A7EA-4BF7E463BDC0 Q36804025-D50900FF-B717-4E8F-A416-A7D28910C6E0 Q37006288-6F28B915-CAE1-41A2-8945-E7A0068FFACB Q37085290-2070EADA-61C4-4380-A9B2-57CC802E8660 Q37257081-34C28878-E233-46AB-86BA-638770EF1B28 Q37262261-26C73C71-703E-4521-9206-C166CD9E5B57 Q37381488-0B3BC898-5760-4A9F-BBFD-3DB6E00DF091 Q37486324-92CAEC0D-8817-432E-B3E0-F93CCCB9BB44 Q37671992-0B9F5D16-5193-4A5B-A31B-33A4CF93F5E3 Q37696642-0A593D48-D571-4A72-B174-D2D7968EE107 Q37707200-36918110-0AA9-483F-BF82-CFCCC7E3C8EC

P2860

Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods.

http://www.wikidata.org/entity/Q33638578

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods.

@ast

Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods.

@en

type

label

Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods.

@ast

Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods.

@en

prefLabel

Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods.

@ast

Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods.

@en

P1433

Q33638578-5C2F9A10-F74D-460F-86DB-7F2F3E724516

P1476

Q33638578-6A869F6D-E2B5-41DA-8952-EA8F591F367B

P2093

Q33638578-215B988E-3688-4D01-A328-067DD0D45510

Q33638578-41E60700-FC3B-4B59-B948-278B5B8EDE99

Q33638578-4521DFBC-2505-471F-9EF3-E7FA74FB45F8

Q33638578-571F7211-E6C4-4B6A-96AF-9DD5F2AF7E68

Q33638578-5DDF148A-52AD-495D-A402-6AB927A35398

Q33638578-92C1AEB9-1532-4074-A37A-5D5631CDD9E9

Q33638578-9C704D91-52FE-498A-9223-25EFA39D367E

Q33638578-AB7F4CEF-1970-4CD8-AA9F-1DF546D5539F

Q33638578-B1279B7B-713C-4E71-A5E2-B734CC72064A

Q33638578-BF888F82-F2D2-48FB-82D0-9977C2F67874

P2860

Q33638578-18F0DCFA-8200-45F5-A2D9-18033ED714BE

Q33638578-1C7FFB72-D583-41CA-8356-B7A404B8AE38

Q33638578-26BE645A-0503-4308-BD3F-CF815C110B91

Q33638578-29171989-9D9A-42E9-AEB5-7780B33BE1B1

Q33638578-2C865105-1471-4AFB-96D0-B89F267F7892

Q33638578-3437971D-A8D9-41EF-AEE6-6107585A77DD

Q33638578-35538EC1-7042-46DC-A565-E8CC0818A565

Q33638578-357AF6F8-63F7-4558-89C7-F9B8D1419AEB

Q33638578-3699B6C2-1765-4352-BEC2-427ED52565BB

Q33638578-39D3E150-08D6-487C-AC4B-8D3CE3646FDA

P2888

Q33638578-989E181C-F95F-4B82-BFB8-CB6F4EDFA180

P304

Q33638578-09D6D5C8-46A2-4E68-8295-AC2DD2B7B49F

P31

Q33638578-5F3AF9E7-9586-444D-A924-629167ED8E80

P356

Q33638578-B6869D4D-6A51-4F9C-9216-F04573A54F9E

P478

Q33638578-43060FD3-662C-4B87-85A2-105B6BF92D2C

P50

Q33638578-7C22EA1E-B003-441E-9130-B19AB4315360

P577

Q33638578-6905B687-EE82-444F-B78F-928B16EF95A1

P5875

Q33638578-65C0753F-FED3-4046-BDBB-7B2F0525B8FB

P6179

Q33638578-3D69FE3B-E9B4-48D6-A2B7-2FD1CE028A3A

P698

Q33638578-F79BB9D6-CD9D-4D1A-B01E-4F0AEEDB558E

P921

Q33638578-277A116E-0271-4D9A-9BA0-175D65317F0E

P932

Q33638578-51B1FD9A-8488-43BB-A033-2058921E0814

P356

P1433

Child and Adolescent Psychiatry and Mental Health

P1476

Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods.

@en

P2093

Anne Marie Albano

http://www.w3.org/2001/XMLSchema#string

Bruce D Waslick

http://www.w3.org/2001/XMLSchema#string

Golda S Ginsburg

http://www.w3.org/2001/XMLSchema#string

James T McCracken

http://www.w3.org/2001/XMLSchema#string

Joel T Sherrill

http://www.w3.org/2001/XMLSchema#string

John C Piacentini

http://www.w3.org/2001/XMLSchema#string

John S March

http://www.w3.org/2001/XMLSchema#string

John T Walkup

http://www.w3.org/2001/XMLSchema#string

Moira A Rynn

http://www.w3.org/2001/XMLSchema#string

Phillip C Kendall

http://www.w3.org/2001/XMLSchema#string

P2860

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

Cognitive behavioural therapy for anxiety disorders in children and adolescents

Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial.

Serotonergic agents in the treatment of social phobia in children and adolescents: a case series.

The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.

Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

SET-C versus fluoxetine in the treatment of childhood social phobia.

Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.

Review of the evidence base for treatment of childhood psychopathology: internalizing disorders.

P2888

P304

1

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1753-2000-4-1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40849983

http://www.w3.org/2001/XMLSchema#string

P6179

1042995586

http://www.w3.org/2001/XMLSchema#string

P698

20051130

http://www.w3.org/2001/XMLSchema#string

P921

P932

2818613

http://www.w3.org/2001/XMLSchema#string